Data News > Costco Offers Weight-Loss Drug Ozempic to Members
- Costco and healthcare partner Sesame are offering weight-loss drugs, including Ozempic, to members
- The $179 three-month prescription plan includes video consultations with a weight-loss doctor
- Costco is the latest company to offer a weight-loss program for members
- Costco's weight loss program is part of a partnership with Sesame
- Analysts have downgraded Costco's stock due to "extreme" valuations
Costco, in partnership with Sesame, has launched a weight-loss program that offers members access to weight-loss drugs, including Ozempic. The program, which costs $179 for three months, also includes video consultations with a weight-loss doctor and an individualized, clinically-appropriate treatment program.
The move by Costco to offer a weight-loss program is part of a growing trend among companies to provide health and wellness services to their members. The program aims to help members achieve their weight-loss goals through medically-supervised treatment.
Costco's decision to offer weight-loss drugs to its members comes at a time when the company's stock has been attracting investor attention. Analysts have been closely watching Costco's stock, with some expressing concerns about its valuation.
Gordon Haskett analyst Chuck Grom recently downgraded Costco's stock, along with several other retailers, citing "extreme" valuations. This downgrade comes amid a broader rally in equities, with some analysts expressing concerns about the current stock prices of certain companies.
Costco's decision to offer weight-loss drug prescriptions to its members for $179 as part of a new program with Sesame reflects a growing trend among companies to provide health and wellness services. However, the company's stock has been downgraded by analysts due to concerns about its valuation.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Costco Offers Weight-Loss Drug Ozempic to Members
By KlickAnalytics Data Insights | April 3, 2024 08:02PM ET
Key Points
- Costco and healthcare partner Sesame are offering weight-loss drugs, including Ozempic, to members
- The $179 three-month prescription plan includes video consultations with a weight-loss doctor
- Costco is the latest company to offer a weight-loss program for members
- Costco's weight loss program is part of a partnership with Sesame
- Analysts have downgraded Costco's stock due to "extreme" valuations
Costco, in partnership with Sesame, has launched a weight-loss program that offers members access to weight-loss drugs, including Ozempic. The program, which costs $179 for three months, also includes video consultations with a weight-loss doctor and an individualized, clinically-appropriate treatment program.
The move by Costco to offer a weight-loss program is part of a growing trend among companies to provide health and wellness services to their members. The program aims to help members achieve their weight-loss goals through medically-supervised treatment.
Costco's decision to offer weight-loss drugs to its members comes at a time when the company's stock has been attracting investor attention. Analysts have been closely watching Costco's stock, with some expressing concerns about its valuation.
Gordon Haskett analyst Chuck Grom recently downgraded Costco's stock, along with several other retailers, citing "extreme" valuations. This downgrade comes amid a broader rally in equities, with some analysts expressing concerns about the current stock prices of certain companies.
Costco's decision to offer weight-loss drug prescriptions to its members for $179 as part of a new program with Sesame reflects a growing trend among companies to provide health and wellness services. However, the company's stock has been downgraded by analysts due to concerns about its valuation.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.